Johnson & Johnson: receives firm offer for Lifescan
(CercleFinance.com) - Johnson & Johnson (J&J) announces that it has received a firm 2.
1 billion dollar offer from Platinum Equity, a private investment company, for its subsidiary LifeScan.
The US health giant recalls that the business in question, which is specialised in blood glucose products, generated net sales of around 1.5 billion dollars last year.
The acceptance period of the offer will end on 15 June, unless extended, and by then J&J will consult staff representative bodies. If accepted, the deal should be finalised by the end of 2018, subject to customary conditions.
Copyright (c) 2018 CercleFinance.com. All rights reserved.
1 billion dollar offer from Platinum Equity, a private investment company, for its subsidiary LifeScan.
The US health giant recalls that the business in question, which is specialised in blood glucose products, generated net sales of around 1.5 billion dollars last year.
The acceptance period of the offer will end on 15 June, unless extended, and by then J&J will consult staff representative bodies. If accepted, the deal should be finalised by the end of 2018, subject to customary conditions.
Copyright (c) 2018 CercleFinance.com. All rights reserved.